Objectives: In rheumatology, five different billion-dollar drugs have emerged in recent years, making this subspecialty the focus of extensive advertising campaigns. Considering this development and the fact that the scientific content of advertisements has been questioned, we initiated a study to determine how evidence-based advertisements are in four leading journals of rheumatology.
Methods: Advertisements were extracted from the journals Arthritis and Rheumatism, Rheumatology, Seminars in Arthritis and Rheumatism and the Journal of Rheumatology, and were evaluated using a standardized score form.
Results: In total, 353 advertisements were obtained, of which 84 were unique. Of the 300 references provided by these unique advertisements, 53 (18%) were considered 'supporting'. In addition, 87 (29%) of the 300 references referred to randomized controlled trials (RCTs), of which 49% supported the claim. The vast majority of RCTs (97%) were sponsored by the advertising company. In the 84 unique advertisements 288 claims were made, of which 190 provided one or more references. Of these 190 claims, 33 (17%) were judged 'well supported'. In total, only four (5%) of the 84 different advertisements were judged 'well supported' and 11 (13%) of the 84 were judged 'misleading' because they contained one or more misleading claims, i.e. claims with references to articles contradicting the claim.
Conclusions: This study indicates that few advertisements in rheumatology journals are entirely evidence-based.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/rheumatology/kel073 | DOI Listing |
JMIR Hum Factors
January 2025
Institute of General Practice, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Background: The internet is a key source of health information, but the quality of content from popular search engines varies, posing challenges for users-especially those with low health or digital health literacy. To address this, the "tala-med" search engine was developed in 2020 to provide access to high-quality, evidence-based content. It prioritizes German health websites based on trustworthiness, recency, user-friendliness, and comprehensibility, offering category-based filters while ensuring privacy by avoiding data collection and advertisements.
View Article and Find Full Text PDFAesthetic Plast Surg
January 2025
Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Rome, Italy.
The proliferation of unlicensed aesthetic medical (UAE) practices in China's plastic surgery industry highlights a pressing global concern, amplified by the growing "beauty economy." Social media platforms perpetuate unattainable beauty standards through edited images and curated pre- and post-operative photos, fueling demand for aesthetic treatments and exacerbating body dysmorphic disorder (BDD). Vulnerable individuals targeted by manipulative advertising often fall victim to unsafe UAE services.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Importance: During buprenorphine treatment for opioid use disorder (OUD), risk factors for opioid relapse or treatment dropout include comorbid substance use disorder, anxiety, or residual opioid craving. There is a need for a well-powered trial to evaluate virtually delivered groups, including both mindfulness and evidence-based approaches, to address these comorbidities during buprenorphine treatment.
Objective: To compare the effects of the Mindful Recovery Opioid Use Disorder Care Continuum (M-ROCC) vs active control among adults receiving buprenorphine for OUD.
Nat Hum Behav
January 2025
Department of Psychology, Education and Child Studies, Erasmus University Rotterdam, Rotterdam, the Netherlands.
Science is crucial for evidence-based decision-making. Public trust in scientists can help decision makers act on the basis of the best available evidence, especially during crises. However, in recent years the epistemic authority of science has been challenged, causing concerns about low public trust in scientists.
View Article and Find Full Text PDFPublic Health
January 2025
Department of Public Health Policy and Management, School of Global Public Health, New York University, 726 Broadway, New York, NY, 10012, United States.
Objective: To assess the substance use disorder (SUD) prevention and response activities that county governments in New York advertise.
Study Design: Cross-sectional study.
Methods: We coded websites of county public health, mental health, emergency, and social service departments to identify whether any government agency provided information about ten evidence-based SUD services.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!